The share price of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) hit a four-year low Monday, falling below $44 a share in early trading, a level the stock hasn't seen since July 2021. What's ...
Self Employed on MSN
Novo Nordisk Rises On IRA Pricing Relief
Novo Nordisk’s closest rival is Eli Lilly, whose GLP-1 drugs have also posted strong demand. A softer read on IRA discounts ...
Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...
The oral version of Wegovy is proving to have similar efficacy, safety, and tolerability when compared to its injectable version. Clinical trial data suggest that Novo Nordisk's oral Wegovy is ahead ...
The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss drugs.
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback